title: [Fluid management and cause of death during shock period in patients with severe burns or burns complicated by inhalation injury].
abstract: OBJECTIVE
  To explore fluid management and cause of death during shock period in severe burns or burns with inhalation injury.
  
  
  METHODS
  One hundred and twelve patients with severe burns or burn complicated by inhalation injury admitted to our hospital from 1991 to 2000 were analyzed. The fluid management and death conditions during shock period were discussed.
  
  
  RESULTS
  The fluid volume for resuscitation could be described as follows: the total fluid volume was 2.2 ml/(%TBSA.kg) including colloid fluid 0.5 ml/(%TBSA.kg), crystalloid fluid 1 ml/(%TBSA.kg)and water 0.7 ml/(%TBSA.kg) during first 24 hours. The total fluid volume was 1.8 ml/(%TBSA.kg) including colloid fluid 0.4 ml/(%TBSA.kg), crystalloid fluid 0.7 ml/(%TBSA.kg) and water 0.7 ml/(%TBSA.kg) during second 24 hours. There were no difference in fluid management between burns and burns with inhalation injury. Seven patients died due to respiratory failure during shock period.
  
  
  CONCLUSIONS
  Many fluid formula can provide guidance for resuscitation and it is very important that early fluid therapy should accord with concrete clinical conditions of patients in order to pass smoothly through shock period. Early fluid management is not different between burns and burns with inhalation injury.
authors.affiliation: Beijing Jishuitan hospital, Beijing 100035, China.
authors.forename: Ming-liang
authors.initials: ML
authors.lastname: Zhang
authors.forename: Chi
authors.initials: C
authors.lastname: Li
authors.forename: Chun-xu
authors.initials: CX
authors.lastname: Ma
mesh_terms: D000293:Adolescent; D000328:Adult; D002056:Burns / Q000401:mortality / Q000628:therapy*; D002423:Cause of Death; D002648:Child; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012774:Shock, Traumatic / Q000401:mortality / Q000628:therapy*; D015208:Smoke Inhalation Injury / Q000401:mortality / Q000628:therapy*